# FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer

> **NCT01170923** · PHASE2 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DEVICE:** FDR-PET
- **DEVICE:** CT

## Key facts

- **NCT ID:** NCT01170923
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2010-08
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01170923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01170923, "FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT01170923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*